SLC22A1 and type 2 diabetes mellitus: Metformin for the frontline therapy for type II diabetes mellitus is mainly absorbed from the small intestine (Graham et al., 2011; Markowicz-Piasecka et al., 2017), and SLC22A1 is the major transporter for its uptake (Han et al., 2015).